Role of Herbal Immunomodulators in in Boosting the Immunity among healthcare workers assigned to COVID-19 wards
- Registration Number
- CTRI/2020/07/026579
- Lead Sponsor
- The Himalaya Drug Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
1.Male or non-pregnant female subjects, aged 18-60 years old,
2.High risk people like Health care workers (Doctors, Nurse, Laboratory technicians, Other hospital support staff), community health care workers assigned to COVID-19 wards.
3. Female of child-bearing potential willing to follow reliable and strict contraceptive measures.
4. Subjects judged to be reliable for compliance for taking medication and capable of recording the effects of the medication and motivated in receiving benefits from the treatment and willing to follow the regulations as per prevailing guidelines.
5. Willing to give written informed consent to participate in the study.
Current active/ Confirmed / relapsed COVID-19 positive cases
2. Pregnant or lactating women.
3. Recent history of significant lung disease like Asthma or Chronic Obstructive Lung Disease (COPD).
4. Unable to take oral medication or suffering from ailments related to absorption.
5. Suffering from Immunocompromising conditions or taking any immunosuppressing therapy.
6. Subjects suffering from severe and uncontrolled metabolic/endocrinal/cardiac/renal/liver disease.
7. The subject with known hypersensitivity to any of the test materials or related compounds.
8. The subject who are unable or unwilling to comply fully with the study protocol.
9. Physician makes a decision that trial involvement is not in subjectsâ?? best interest, or any condition that does not allow the protocol to be followed safely.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method